3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
14
OTHER_GOV
2
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Breast Neoplasms
55
Carcinoma, Non-Small-Cell Lung
33
Stomach Neoplasms
28
Colorectal Neoplasms
26
Small Cell Lung Carcinoma
19
Lung Neoplasms
18
Rectal Neoplasms
16
Pancreatic Neoplasms
14
Neoplasms
14
Neoplasm Metastasis
14
Uterine Cervical Neoplasms
12
Esophageal Neoplasms
12
Ovarian Neoplasms
11
Nasopharyngeal Carcinoma
11
Carcinoma, Hepatocellular
11
Recurrence
10
Leukemia, Myeloid, Acute
10
Melanoma
9
Esophageal Squamous Cell Carcinoma
8
Colonic Neoplasms
8
Triple Negative Breast Neoplasms
7
Lymphoma, Non-Hodgkin
7
Head and Neck Neoplasms
7
Hodgkin Disease
6
Cholangiocarcinoma
6
Adenocarcinoma of Lung
6
Squamous Cell Carcinoma of Head and Neck
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms, Germ Cell and Embryonal
5
Multiple Myeloma
5
Interventions
lithium sulfate
1
fasudil
1
Lithium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
OTHER_GOV
×
Cognitive Dysfunction
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled
NCT06051240
2024-04-12
LiBRA
Region Stockholm
Phase 2
Recruiting
84 enrolled